| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/14/2006 | WO2006095624A1 Protease inhibitor |
| 09/14/2006 | WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR |
| 09/14/2006 | US20060205806 Synergistic combination |
| 09/14/2006 | US20060205801 Crystal and process for producing the same |
| 09/14/2006 | US20060205796 Method for treating pain or pruritis by administering opinoid receptor agonist comprising 2-phenylbenzothiazoling derivative |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205782 Method of providing an antihistaminic effect in a hepatically impaired patient |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205745 Microcrystal |
| 09/14/2006 | US20060205743 Protein kinase inhibitors |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205710 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205707 adenosine triphosphate inhibitors used for the treatment of cancer; anticarcinogenic agents |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205673 2-Amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 09/14/2006 | US20060205672 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060204593 Superoxide anion decomposing agent |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204579 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal |
| 09/14/2006 | US20060204577 Pharmaceutical Compositions of Drugs and Neutralized Acidic Polymers |
| 09/14/2006 | US20060204518 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204517 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204501 Drug for cancer therapy |
| 09/14/2006 | US20060204459 Use of tyrosine inhibitors for whitening human skin and treating melanocyted dysfunction associated diseases |
| 09/14/2006 | DE102005008702A1 Method for decreasing an energy loss (light energy transfer) from body cells, comprises administering natural remedies of cascading revenol, maximol solution, neways noni, pro em san, pro basan, pro curmin and ming gold |
| 09/14/2006 | CA2599872A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | CA2598899A1 Novel hsp90 inhibitor |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700604A1 Alga extract and sugar hydrolase inhibitor containing the same |
| 09/13/2006 | EP1699806A1 Glycosaminoglycan (gag) mimetics |
| 09/13/2006 | EP1699482A2 Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 09/13/2006 | EP1699466A2 New compounds useful as metal chelators |
| 09/13/2006 | EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 09/13/2006 | EP1511752B1 Camptothecins with a modified lactone ring |
| 09/13/2006 | EP1497662B1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of sepsis |
| 09/13/2006 | EP1487424B1 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases |
| 09/13/2006 | EP1485067B1 Materials containing multiple layers of vesicles |
| 09/13/2006 | EP1483257B1 Quinazoline compounds useful in therapy |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1430060B1 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1366074B1 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1343486B1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 09/13/2006 | EP1305635B1 Methods to identify compounds that modulate rage |
| 09/13/2006 | EP1284720B1 L-fmau for the treatment of hepatitis delta viral infection |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1246617B1 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1229938B1 Potentiation of the activity of sn-38 prodrugs |
| 09/13/2006 | EP1200040B8 Two-component composition for cosmetic or pharmaceutical use |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1196431B1 A substantially crystalline form of melagatran |
| 09/13/2006 | EP1196154B1 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 09/13/2006 | EP1183050B1 Method for producing an injectable medicament preparation |
| 09/13/2006 | EP1179344B1 Release-regulating preparations |
| 09/13/2006 | EP1095062B1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 09/13/2006 | EP1088084B1 Erythropoietin analog-human serum albumin fusion protein |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | CN1833031A Casein hydrolyzate, process for producing the same and use thereof |
| 09/13/2006 | CN1832958A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/13/2006 | CN1832948A 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1830973A 9-anthrone lactone compounds, preparing method and use thereof |
| 09/13/2006 | CN1830323A Face beaufifying forehead nourishing decoction and its preparation method |
| 09/13/2006 | CN1830316A Food mother material and its making method |
| 09/13/2006 | CN1830313A SOD cordyceps sinensis regulating water |
| 09/13/2006 | CN1830297A Health-care vermicellic with codonopsis pilosula |
| 09/13/2006 | CN1274800C Pomegranate wine making process |
| 09/13/2006 | CN1274716C Method for extracting albumin transferrin with iron supplemented and antibacterial function |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274685C Benzimidazol derivatives modulate che mokine receptors |
| 09/13/2006 | CN1274678C New benzothiazine and benzothiadiazine compounds,its preparation process and pharmaceutical composition containing said compounds |
| 09/13/2006 | CN1274676C Quinoline and quinazoline derivatives |
| 09/13/2006 | CN1274669C Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 09/13/2006 | CN1274667C Cycloalkenone derivative |
| 09/13/2006 | CN1274361C Soybean peptide, its preparation and application |
| 09/13/2006 | CN1274306C Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use |
| 09/12/2006 | US7105695 Anticarcinogenic agents formed by phosphorylation |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105675 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105669 Quinazoline derivatives |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |